MAPT and Alzheimer disease: Here, we demonstrated that NTA-tau is more tightly associated with tau-PET in AD than Aβ-PET and MRI neurodegeneration measurements, and that NTA-tau can track tau deposition in cognitively impaired amyloid-β positive individuals [44].